IP Library › Granted Patent US 7,994,329
Granted Patent B2
US 7,994,329 · App. 11/424,885 · Granted Aug 9, 2011

Growth hormone secretagogue receptor type 1A agonists

Assignee: Helsinn Therapeutics (U.S.), Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,994,329
App. No.
11/424,885
Granted
Aug 9, 2011
Kind
B2
Abstract

Compounds that are ligands for the growth hormone secretagogue receptor type 1A (GHS-R 1A), as well as pharmaceutically acceptable salts of such compounds, are useful for the manufacture of medicaments for the regulation of food intake.

Claims (2)

1. A method for treating anorexia, comprising administering to a subject in need thereof a compound that is an agonist for the growth hormone secretagogue receptor type 1A (GHS-R 1A), wherein the agonist is NNC 26-1291 or a pharmaceutically acceptable salt thereof, in an amount effective for such treatment,

2. The method of claim 1 wherein said compound is orally administered.

Assignments (8)
CORRECTIVE ASSIGNMENT TO CORRECT THE COUNTRY OF THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED ON REEL 036903 FRAME 0809. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT COUNTRY OF THE ASSIGNEE'S ADDRESS. Recorded Dec 14, 2015
From: HELSINN THERAPEUTICS (U.S.), INC.
To: HELSINN HEALTHCARE SA
Reel/Frame 037288/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2015
From: HELSINN THERAPEUTICS (U.S.), INC.
To: HELSINN HEALTHCARE SA
Reel/Frame 036903/0809 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF ASSIGNOR'S NAME AND TO CORRECT THE NAME OF THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 023869 FRAME 0734. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNOR'S NAME SHOULD HAVE BEEN: MICHAEL ANKERSEN; AND THE ASSIGNEE'S NAME SHOULD HAVE BEEN: NOVO NORDISK A/S. Recorded Feb 1, 2010
From: ANKERSEN, MICHAEL
To: NOVO NORDISK A/S
Reel/Frame 023951/0611 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2010
From: ANKERSON, MICHAEL
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023869/0734 →
MERGER Recorded Jan 29, 2010
From: SAPPHIRE THERAPEUTICS, INC.
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023869/0787 →
MERGER Recorded Jan 14, 2010
From: SAPPHIRE THERAPEUTICS, INC.
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023778/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2009
From: NOVO NORDISK A/S
To: SAPPHIRE THERAPEUTICS
Reel/Frame 022277/0160 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2006
From: ANDERSEN, MAIBRITT BANSHOLM; HANSEN, BIRGIT SEHESTED; RAUN, KIRSTEN; TULLIN, SOREN; THIM, LARS
To: NOVO NORDISK A/S
Reel/Frame 018556/0043 →
Continuity (5)
Continuation 11150736 · Jun 10, 2005
Continuation 10649386 · Aug 27, 2003
Continuation 09771770 · Jan 29, 2001
Provisional Application 60181303 · Feb 9, 2000
Related Publication 20070066540A1 · Mar 22, 2007